Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Secured Bio is a biosecurity company focused on developing advanced screening technologies for DNA synthesis to prevent the misuse of synthetic biology. The company provides a platform that enables DNA synthesis providers to rapidly and accurately screen orders against databases of known pathogens and toxins without compromising customer privacy. By utilizing secure multi-party computation and advanced bioinformatics, Secured Bio aims to build a safety layer for the global bioeconomy, ensuring that the tools of genetic engineering remain accessible while mitigating the risks of accidental or intentional biological threats.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Secured.